Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FT825 |
Trade Name | |
Synonyms | FT-825|FT 825|ONO-8250|ONO 8250|ONO8250 |
Drug Descriptions |
FT825 is a chimeric antigen receptor (CAR) T cell therapy targeting ERBB2 (HER2), which potentially decreases growth of ERBB2 (HER2)-expressing tumors (Journal for ImmunoTherapy of Cancer 2023;11). |
DrugClasses | HER2 (ERBB2) Immune Cell Therapy 6 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + FT825 | Cetuximab FT825 | 0 | 1 |
FT825 | FT825 | 0 | 1 |